Literature DB >> 24573694

In vivo genome-wide binding of Id2 to E2F4 target genes as part of a reversible program in mice liver.

Ivan Ferrer-Vicens1, Ángela L Riffo-Campos, Rosa Zaragozá, Concha García, Gerardo López-Rodas, Juan R Viña, Luis Torres, Elena R García-Trevijano.   

Abstract

The inhibitor of differentiation Id2, a protein lacking the basic DNA-binding domain, is involved in the modulation of a number of biological processes. The molecular mechanisms explaining Id2 pleiotropic functions are poorly understood. Id2 and E2F4 are known to bind simultaneously to c-myc promoter. To study whether Id2 plays a global role on transcriptional regulation, we performed in vivo genome-wide ChIP/chip experiments for Id2 and E2F4 in adult mouse liver. An Id2-containing complex was bound to a common sequence downstream from the TSS on a subset of 442 E2F4 target genes mainly related to cell development and chromatin structure. We found a positive correlation between Id2 protein levels and the expression of E2F4/Id2 targets in fetal and adult liver. Id2 protein stability increased in fetal liver by interaction with USP1 de-ubiquitinating enzyme, which was induced during development. In adult liver, USP1 and Id2 levels dramatically decreased. In differentiated liver tissue, when Id2 concentration was low, E2F4/Id2 was bound to the same region as paused Pol II and target genes remained transcriptionally inactive. Conversely, in fetal liver when Id2 levels were increased, Id2 and Pol II were released from gene promoters and target genes up-regulated. During liver regeneration after partial hepatectomy, we obtained the same results as in fetal liver. Our results suggest that Id2 might be part of a reversible development-related program involved in the paused-ON/OFF state of Pol II on selected genes that would remain responsive to specific stimuli.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24573694     DOI: 10.1007/s00018-014-1588-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  41 in total

1.  Degradation of Id proteins by the ubiquitin-proteasome pathway.

Authors:  M A Bounpheng; J J Dimas; S G Dodds; B A Christy
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

2.  Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells.

Authors:  Egle Balciunaite; Alexander Spektor; Nathan H Lents; Hugh Cam; Hein Te Riele; Anthony Scime; Michael A Rudnicki; Richard Young; Brian David Dynlacht
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

3.  A chromatin landmark and transcription initiation at most promoters in human cells.

Authors:  Matthew G Guenther; Stuart S Levine; Laurie A Boyer; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2007-07-13       Impact factor: 41.582

4.  Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters.

Authors:  Leighton J Core; Joshua J Waterfall; John T Lis
Journal:  Science       Date:  2008-12-04       Impact factor: 47.728

5.  Mapping and quantifying mammalian transcriptomes by RNA-Seq.

Authors:  Ali Mortazavi; Brian A Williams; Kenneth McCue; Lorian Schaeffer; Barbara Wold
Journal:  Nat Methods       Date:  2008-05-30       Impact factor: 28.547

6.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence.

Authors:  C Murre; P S McCaw; H Vaessin; M Caudy; L Y Jan; Y N Jan; C V Cabrera; J N Buskin; S D Hauschka; A B Lassar
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

7.  Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F.

Authors:  Silvia Coma; Dhara N Amin; Akio Shimizu; Anna Lasorella; Antonio Iavarone; Michael Klagsbrun
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

8.  Contribution of the helix-loop-helix factor Id2 to regulation of vascular smooth muscle cell proliferation.

Authors:  Martin E Matsumura; David R Lobe; Coleen A McNamara
Journal:  J Biol Chem       Date:  2001-11-08       Impact factor: 5.157

9.  Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype.

Authors:  Jung Min Kim; Kalindi Parmar; Min Huang; David M Weinstock; Carrie Ann Ruit; Jeffrey L Kutok; Alan D D'Andrea
Journal:  Dev Cell       Date:  2009-02       Impact factor: 12.270

10.  NELF-mediated stalling of Pol II can enhance gene expression by blocking promoter-proximal nucleosome assembly.

Authors:  Daniel A Gilchrist; Sergei Nechaev; Chanhyo Lee; Saikat Kumar B Ghosh; Jennifer B Collins; Leping Li; David S Gilmour; Karen Adelman
Journal:  Genes Dev       Date:  2008-07-15       Impact factor: 11.361

View more
  4 in total

1.  Early developmental gene enhancers affect subcortical volumes in the adult human brain.

Authors:  Martin Becker; Tulio Guadalupe; Barbara Franke; Derrek P Hibar; Miguel E Renteria; Jason L Stein; Paul M Thompson; Clyde Francks; Sonja C Vernes; Simon E Fisher
Journal:  Hum Brain Mapp       Date:  2016-02-18       Impact factor: 5.038

2.  Cellular Id1 inhibits hepatitis B virus transcription by interacting with the novel covalently closed circular DNA-binding protein E2F4.

Authors:  Jie Wei; Yueyuan Shi; Chunhong Zou; Hongpeng Zhang; Hui Peng; Shilei Wang; Lulu Xia; Yuan Yang; Xiang Zhang; Junye Liu; Hua Zhou; Miao Luo; Ailong Huang; Deqiang Wang
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

3.  Sex Difference of Egfr Expression and Molecular Pathway in the Liver: Impact on Drug Design and Cancer Treatments?

Authors:  Lishi Wang; Jianqi Xiao; Weikuan Gu; Hong Chen
Journal:  J Cancer       Date:  2016-03-20       Impact factor: 4.207

4.  E2F4 Promotes the Proliferation of Hepatocellular Carcinoma Cells through Upregulation of CDCA3.

Authors:  Junye Liu; Lulu Xia; Shilei Wang; Xuefei Cai; Xiaoli Wu; Chunhong Zou; Baoju Shan; Miao Luo; Deqiang Wang
Journal:  J Cancer       Date:  2021-06-22       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.